Effects of enalapril in rats with pressure overload cardiac hypertrophy

General Pharmacology

Volumn 28, Issue 4, 1997, Pages 531-533

  Di Paola Eugenio, Donato ^a   Pietro, Gareri ^a   Rosario, Mattace ^b   De Sarro, Giovambattista ^a  

^a UNIVERSITY MEDITERRANEA OF REGGIO CALABRIA   (Italy)

^b NONE

Author keywords

Angiotensin converting enzyme inhibitors; Cardiac hypertrophy; Enalapril; Heart failure

Indexed keywords

ENALAPRIL;

ANIMAL EXPERIMENT; ARTICLE; BLOOD PRESSURE; HEART FUNCTION; HEART HYPERTROPHY; HEART LEFT VENTRICLE FUNCTION; HEMODYNAMICS; MALE; NONHUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RAT;

ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANIMALS; BLOOD PRESSURE; CARDIOMEGALY; ENALAPRIL; HEART; HEMODYNAMIC PROCESSES; MALE; ORGAN SIZE; RATS; RATS, INBRED WKY; VASCULAR RESISTANCE;

EID: 0030940296     PISSN: 03063623     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0306-3623(96)00234-0     Document Type: Article

References (9)

1. Clozel J. P. and Hefti F. (1988) Cilazapril prevents the development of cardiac hypertrophy and the decrease of coronary vascular reserve in spontaneously hypertensive rats. J. Cardiovasc. Pharmacol. 11 (5), 568-572.
2. Fernandez D., Snedden W., Fernandez P. G., Nath C., Vasdev S., Triggle C. R. and Lee C. (1988) Cardiac hypertrophy in experimental hypertension: interaction of the sodium ion, blood pressure and lisinopril. Can. J. Cardiol. 4 (1), 44-48.
3. Kannel W. B., Gordon T. and Offutt D. ( 1969) Left ventricular hypertrophy by electrocardiogram: prevalence, incidence and mortality in the Framingham Study. Ann. Intern. Med. 71, 89-105.
4. Linz W., Scholkens B. A. and Ganten D. ( 1989) Converting enzyme inhibition specifically prevents the development and induces regression of cardiac hypertrophy in rats. Clin. Exp. Hypertens. 11 (7), 1325-1350.
5. Messerli F. H. and Ketelhut R. (1991) Left ventricular hypertrophy: an independent risk factor. J. Cardiovasc. Pharmacol. 1 (suppl. 4), S59.
6. Pfeffer J. M., Pfeffer M. A. and Braunwald E. (1985) Influence of chronic captopril therapy on the infarcted left ventricle of the rat. Circ. Res. 57, 84-95.
7. Schelling P., Fischer H. and Ganten D. (1991) Angiotensin and cell growth: a link to cardiovascular hypertrophy? (editorial) J. Hypertension, 9 (1), 3-15.
8. Sweet C. S., Emmert S. E., Stabilito I. I. and Ribeiro L. G. T. (1987) Increased survival in rats with congestive heart failure treated with enalapril. J. Cardiovasc. Pharmacol. 10 (6), 636-642.
9. Weber J. R. (1988) Left ventricular hypertrophy: its prime importance as a controllable risk factor. Am. Heart J. 116, 272-279.